Literature DB >> 28387618

Effectiveness of endoscopic surgery for supratentorial hypertensive intracerebral hemorrhage: a comparison with craniotomy.

Xinghua Xu, Xiaolei Chen, Fangye Li, Xuan Zheng, Qun Wang, Guochen Sun, Jun Zhang, Bainan Xu.   

Abstract

OBJECTIVE The goal of this study was to investigate the effectiveness and practicality of endoscopic surgery for treatment of supratentorial hypertensive intracerebral hemorrhage (HICH) compared with traditional craniotomy. METHODS The authors retrospectively analyzed 151 consecutive patients who were operated on for treatment of supratentorial HICH between January 2009 and June 2014 in the Department of Neurosurgery at Chinese PLA General Hospital. Patients were separated into an endoscopy group (82 cases) and a craniotomy group (69 cases), depending on the surgery they received. The hematoma evacuation rate was calculated using 3D Slicer software to measure the hematoma volume. Comparisons of operative time, intraoperative blood loss, Glasgow Coma Scale score 1 week after surgery, hospitalization time, and modified Rankin Scale score 6 months after surgery were also made between these groups. RESULTS There was no statistically significant difference in preoperative data between the endoscopy group and the craniotomy group (p > 0.05). The hematoma evacuation rate was 90.5% ± 6.5% in the endoscopy group and 82.3% ± 8.6% in the craniotomy group, which was statistically significant (p < 0.01). The operative time was 1.6 ± 0.7 hours in the endoscopy group and 5.2 ± 1.8 hours in the craniotomy group (p < 0.01). The intraoperative blood loss was 91.4 ± 93.1 ml in the endoscopy group and 605.6 ± 602.3 ml in the craniotomy group (p < 0.01). The 1-week postoperative Glasgow Coma Scale score was 11.5 ± 2.9 in the endoscopy group and 8.3 ± 3.8 in the craniotomy group (p < 0.01). The hospital stay was 11.6 ± 6.9 days in the endoscopy group and 13.2 ± 7.9 days in the craniotomy group (p < 0.05). The mean modified Rankin Scale score 6 months after surgery was 3.2 ± 1.5 in the endoscopy group and 4.1 ± 1.9 in the craniotomy group (p < 0.01). Patients had better recovery in the endoscopy group than in the craniotomy group. Data are expressed as the mean ± SD. CONCLUSIONS Compared with traditional craniotomy, endoscopic surgery was more effective, less invasive, and may have improved the prognoses of patients with supratentorial HICH. Endoscopic surgery is a promising method for treatment of supratentorial HICH. With the development of endoscope technology, endoscopic evacuation will become more widely used in the clinic. Prospective randomized controlled trials are needed.

Entities:  

Keywords:  GCS = Glasgow Coma Scale; HICH = hypertensive intracerebral hemorrhage; ICH = intracerebral hemorrhage; STICH = Surgical Trial in Intracerebral Haemorrhage; craniotomy, vascular disorders; endoscopic surgery; hypertensive intracerebral hemorrhage; mRS = modified Rankin Scale

Mesh:

Year:  2017        PMID: 28387618     DOI: 10.3171/2016.10.JNS161589

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  21 in total

Review 1.  A combination of Deferoxamine mesylate and minimally invasive surgery with hematoma lysis for evacuation of intracerebral hemorrhage.

Authors:  Aditya S Pandey; Badih J Daou; Neeraj Chaudhary; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2019-12-02       Impact factor: 6.200

2.  Endoscopic Surgery versus External Ventricular Drainage Surgery for Severe Intraventricular Hemorrhage.

Authors:  Ping Song; Fa-Liang Duan; Qiang Cai; Jing-Lei Wu; Xiao-Bin Chen; Yuan Wang; Cong-Gang Huang; Ji-Qiang Li; Zhu-Qiang He; Qiao-Chun Huang; Mei Liu; Yan-Gao Zhang; Ming Luo
Journal:  Curr Med Sci       Date:  2018-10-20

3.  Comparison of endoscopic evacuation, stereotactic aspiration and craniotomy for the treatment of supratentorial hypertensive intracerebral haemorrhage: study protocol for a randomised controlled trial.

Authors:  Xinghua Xu; Yi Zheng; Xiaolei Chen; Fangye Li; Huaping Zhang; Xin Ge
Journal:  Trials       Date:  2017-06-28       Impact factor: 2.279

4.  Endoscopic hematoma removal of supratentorial intracerebral hemorrhage under local anesthesia reduces operative time compared to craniotomy.

Authors:  Masahito Katsuki; Yukinari Kakizawa; Akihiro Nishikawa; Yasunaga Yamamoto; Toshiya Uchiyama
Journal:  Sci Rep       Date:  2020-06-25       Impact factor: 4.379

Review 5.  Efficacy and safety of minimal invasive surgery treatment in hypertensive intracerebral hemorrhage: a systematic review and meta-analysis.

Authors:  Yiping Tang; Fengqiong Yin; Dengli Fu; Xinhai Gao; Zhengchao Lv; Xuetao Li
Journal:  BMC Neurol       Date:  2018-09-03       Impact factor: 2.474

6.  Treatment of intracranial hemorrhage with neuroendoscopy guided by body surface projection.

Authors:  Shengli Qiu; Tao Liu; Guanghui Cao; Kun Wu; Tingsheng Zhao
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  Interval between endoscopic surgery and decreased intracranial pressure related to putaminal hemorrhage prognosis.

Authors:  Hiroki Uchikawa; Shigeo Yamashiro; Yasuyuki Hitoshi; Makoto Yoshikawa; Akimasa Yoshida; Shigetoshi Yano
Journal:  Surg Neurol Int       Date:  2020-04-25

8.  Comparison of endoscopic evacuation, stereotactic aspiration, and craniotomy for treatment of basal ganglia hemorrhage.

Authors:  Wei Guo; Haixiao Liu; Zhijun Tan; Xiaoyang Zhang; Junmei Gao; Lei Zhang; Hao Guo; Hao Bai; Wenxing Cui; Xunyuan Liu; Xun Wu; Jianing Luo; Yan Qu
Journal:  J Neurointerv Surg       Date:  2019-07-12       Impact factor: 5.836

9.  A Meta-analysis for Evaluating Efficacy of Neuroendoscopic Surgery versus Craniotomy for Supratentorial Hypertensive Intracerebral Hemorrhage.

Authors:  Taek Min Nam; Young Zoon Kim
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2019-03-31

10.  Efficacy of neuroendoscopic surgery versus craniotomy for supratentorial hypertensive intracerebral hemorrhage: A meta-analysis of randomized controlled trials.

Authors:  Xu-Hui Zhao; Su-Zhen Zhang; Jin Feng; Zhen-Zhong Li; Zeng-Lu Ma
Journal:  Brain Behav       Date:  2019-11-19       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.